Pipeline

Therapeutic Modality Indication Research IND Enabling Phase 1 Phase 2 Phase 3
Plasma Proteins
Alzheimer’s Disease – Mild to Moderate
Plasma Proteins Alzheimer’s Disease – Mild to Moderate
 
Alzheimer’s Disease – Advanced
Alzheimer’s Disease – Advanced
 
Parkinson’s Disease
Parkinson’s Disease
 
Undisclosed Disease
Undisclosed Disease
 
CCR3 Antagonist
WetAMD
CCR3 Antagonist WetAMD
 
Neurodegenerative Disease
Neurodegenerative Disease
 
Neurodegenerative Disease
Inflammatory Disease
 
TIMP2
Neurocognitive Disease
TIMP2 Neurocognitive Disease        
Extracorporeal Therapy
Dialysis Related Dementia/td>
Extracorporeal Therapy Dialysis Related Dementia
   
Novel Factors
Novel Factors